Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:32 AM
Ignite Modification Date:
2025-12-25 @ 3:32 AM
NCT ID:
NCT04573205
Eligibility Criteria:
Inclusion Criteria:
* Adults ≥ 50 years or between 18-40 years
* Man or woman
* God health
* Written informed consent
Exclusion Criteria:
* Previous vaccination against TBE
* Previous TBE infection
* Allergy or hypersensitivity to any substance in the vaccine
* Previously known or suspected infection with Japanese encephalitis, Dengue virus, West Nile fever or Yellow fever
* Information on previous vaccination against Yellow fever or Japanese encephalitis
* Acute illness, eg fever with malaise
* Immunosuppression, due to medication or disease
* Previous treatment with Rituximab or equivalent
* Autoimmune disease, including diabetes (diet or tablet-treated diabetes with good metabolic control is accepted, HbA1c \< 6 %)
* Obesity, BMI \> 40
* Moderate to severe renal failure including hemodialysis, estimated GFR \< 30.
* Blood transfusion or immunoglobulins \<3 months ago
* Pregnancy
* Any other illness where the investigator consider the subject unsuitable for the study
* The study subject does not want to participate
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04573205
Study Brief:
Protocol Section:
NCT04573205